Saxenda and Sinusitis - a phase IV clinical study of FDA data

Summary:

Sinusitis is reported as a side effect among people who take Saxenda (liraglutide recombinant), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Synthroid, and have Weight decreased.

The phase IV clinical study analyzes which people have Sinusitis when taking Saxenda. It is created by eHealthMe based on reports of 6,333 people who have side effects when taking Saxenda from the FDA, and is updated regularly.

What is Saxenda?

Saxenda has active ingredients of liraglutide recombinant. It is often used in weight loss. eHealthMe is studying from 6,735 Saxenda users. Check the latest studies of Saxenda.

What is Sinusitis?

Sinusitis (inflammation of sinus) is found to be associated with 2,400 drugs and 2,725 conditions by eHealthMe. Check the latest studies of Sinusitis.

On Jul, 10, 2026

6,333 people reported to have side effects when taking Saxenda.
Among them, 38 people (0.6%) have Sinusitis.

Among these 38 people:

How long have people been on Saxenda when they have Sinusitis? *

What is the gender of people who have Sinusitis when taking Saxenda? *

female: 78.95 %
male: 21.05 %

What is the age of people who have Sinusitis when taking Saxenda? *

What are other drugs people take besides Saxenda? *

Synthroid: 12 people, 31.58%
Tylenol: 9 people, 23.68%
Singulair: 8 people, 21.05%
Cosentyx: 8 people, 21.05%
Contrave: 7 people, 18.42%
Omega 3: 7 people, 18.42%
Methylprednisolone: 7 people, 18.42%
Ocrevus: 7 people, 18.42%
Cetirizine Hydrochloride: 7 people, 18.42%
Acetaminophen: 7 people, 18.42%

What are other side effects people have besides Sinusitis? *

Cough: 14 people, 36.84%
Headache (pain in head): 13 people, 34.21%
Fatigue (feeling of tiredness): 13 people, 34.21%
Nasopharyngitis (inflammation of the nasopharynx): 12 people, 31.58%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 10 people, 26.32%
Rashes (redness): 10 people, 26.32%
Rhinorrhea (watery mucus discharge from the nose): 9 people, 23.68%
Infusion Related Reaction: 8 people, 21.05%
Cellulitis Orbital (acute spread of infection into the eye socket): 7 people, 18.42%
Facial Pain: 7 people, 18.42%

What are the existing conditions these people have? *

Weight Decreased: 10 people, 26.32%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 7 people, 18.42%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 15.79%
Psoriasis (immune-mediated disease that affects the skin): 6 people, 15.79%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 10.53%
Dyspnea (difficult or laboured breathing): 3 people, 7.89%
Asthma: 3 people, 7.89%
Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 7.89%
Stress And Anxiety: 1 person, 2.63%
Nausea (feeling of having an urge to vomit): 1 person, 2.63%

* Approximation only. Some reports may have incomplete information.

Do you take Saxenda and have Sinusitis?

- Check whether Sinusitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Saxenda:

Saxenda (6,735 reports)

Sinusitis treatments and more:

Sinusitis (153,485 reports)

Browse all side effects of Saxenda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinusitis:

Sinusitis (2,400 drugs)

Browse all the conditions that are associated with Sinusitis:

Sinusitis (2,725 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on liraglutide recombinant (the active ingredients of Saxenda) and Saxenda (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.